ADDITIONAL TECHNIQUES
CARE
PERSONALIZED
Techniques adapted to patient needs
AHEAD OF
GENETIC DISEASES
A major reduction in the risk of genetic diseases
OPTIMIZE THE
CHANCES OF GROSSESSE
Better treatments for better results
EMBRYOSCOPE
Super incubator
It is a high-tech incubator equipped with a camera, a image capture system which allows observation, in time real, embryo cell division and record the evolution of embryos minute by minute, 24 hours a day.The advantages of the embryoscope: It allows embryos to be observed without having to take them out of the incubator and bring them to the microscope.Embryos are preserved under extremely stable conditions, with no changes in temperature or pH.The embryologist gets more information about the embryos, which allows him to better select them.
IMSI
Intra Cytoplasmic Morphologically Selected Sperm Injection
IMSI is an technique that allows the selection of the best sperm cell. This technique optimizes the chances of pregnancy and reduces the risk of miscarriages.
With IMSI, the sperm image can be increased up to 10.000 times: sperm with lots of vacuoles (imperfections) and sperm with abnormalities are discarded at the DNA level.
so
.png)
EndomeTRIO® TEST
Endometrial receptivity
The endometrium is a tissue covering the inside of the uterus in which the embryo implants and resides during pregnancy.
EndomeTRIO is a comprehensive endometrial analysis that includes the following tests:
ERA: Analysis of endometrial receptivity to know the implantation window.
EMMA: Metagenomic analysis of the endometrial microbiome.
ALICE: Analysis of endometrial receptivity to know the endometrial flora.
ZYMÖT®
Optimize the
sperm selection
ZyMöT® Sperm Separator selects sperm to optimize IVF results.
This complementary technique situates sperm as if they were in the female genital tract. The sperm thus crosses several obstacles and
only the best sperm are guarded.
ZyMot® is indicated for patients with high sperm DNA fragmentation.
DNI
Diagnosis Near Implantation
DNI is offered to patients who are likely to transmit a serious illness to their future children. A biopsy is performed on embryos obtained in the laboratory. This biopsy can be done at J3 or J5, at the blastocyst stage. The extracted cells are analyzed to select healthy embryos. To guarantee total professionalism, Girexx entrusts the realization of IPRs to a laboratory specialized in medical genetics.
.png)
TEST qCARRIER®
Genetic
prevention
The qCarrier® test can detect in future parents the presence of genes that could be responsible for genetic diseases in the future child.
Many subjects are healthy carriers, that is, the disease does not manifest itself.
The qCarrier® test detects 250 genetic diseases that have a significant impact on newborn health.